Veko Auriko Drops for (Enrofloxacin Sulphadiazine) Dogs and Cats (15ml)
Auriko eardrop is indicated as a treatment for canine otitis externa or external ear infections complicated by bacterial and fungal organisms. Enrofloxacin is a fluoroquinolone antibiotic with activity against a broad spectrum of both gram negative and gram positive bacteria.Silver Sulphadiazine is synthesized from silver nitrate and sodium sulphadiazine. It has a wide spectrum of antimicrobial activity.
Composition: ENROFLOXACIN + SILVER SULPHADIAZINE
Class: Antifungal – Antibacterial
Indications/Uses
- Treatment of Otitis in dogs & cats.
Directions for use:
- Instill 5-10 drops into each ear after cleaning the ear with an ear cleanser.
- Gently massage the base of the ear.
- Follow this twice a day for a week or as recommended by the veterinarian.
Suitable for Dogs and Cats
_______________________________
Disclosure: Prescription medicines listed on iThinkPets.com are dispensed and delivered through licensed veterinary pharmacy partners. Upon acceptance of your order, the details of the authorized vendor fulfilling your prescription will be shared with you. Order confirmation and delivery are strictly subject to (i) verification of a valid veterinary prescription, and (ii) availability of the prescribed product with the licensed partner pharmacy. iThinkPets.com acts solely as a facilitator between the customer and the licensed pharmacy and does not itself dispense or sell prescription medicines.
Disclaimer: While iThinkPets.com strives to provide accurate, expert-reviewed, and reliable information, it should not be considered a substitute for professional veterinary advice. The content shared here is intended for general informational purposes only and may not cover all conditions or treatments. Always consult your veterinarian for personalized guidance regarding your pet’s health, diagnosis, and treatment. iThinkPets.com aims to support—not replace—the trusted relationship between you and your veterinarian.



Reviews
There are no reviews yet.